Patriot Scientific

But this is a poison pill for a joint entity PDS, not a poison pill for PTSC along. This is huge distinction. Do not take that poison pill as the protection we (retail shareholders) need in case any takeover, and don't trust the "fair price" will be fair to us.

In the event of an offer for PTSC, the value of 50% of PDS plays a significant part in the valuation. As TPL kindly provided an indicative price for PDS, the poison pill still exists for PTSC alone.

As to a "fair price" valuation, I would again respectfully refer you to the options available at Delaware Chancery Court whereby the court determines a fair value based on all evidence provided. This is the second poison pill.

Be well